The Study
The PPARβ/δ activator GW501516 prevents the down-regulation of AMPK caused by a high-fat diet in liver and amplifies the PGC-1α-Lipin 1-PPARα pathway leading to increased fatty acid oxidation.
This study looked at what happened in mice's livers after they were given a drug while eating a bad diet. It shows some links between the drug and certain body changes, but it doesn’t prove the drug caused them — other things could be involved.
Analysis score
Maximum 44 for a cross-sectional study.
Where the score came from
Mice eating too much fat had lazy livers that stored fat instead of burning it. A drug called GW501516 woke up the fat-burning system in their liver cells.
Where does this study sit?
Reviews of RCTs (Meta-analyses)
Max 100Randomized Trials
Max 90Reviews of Cohort Studies
Max 85Cohort Studies
Max 72Reviews of Case-Control Studies
Max 63Case-Control Studies
Max 58Cross-Sectional & Case Series
Max 50Expert Opinion
Max 512 / 100
Quality score
Snapshots of a population at a single point in time, or descriptions of small groups. Can identify correlations and prevalence, but cannot determine cause and effect.
Key takeaways
Summary
Based on the study abstract and findings.
- 1This shows the drug helps livers process fat better under high-fat stress, which could help with obesity-related liver problems—but it’s only been tested in mice.
- 2GW501516 increased fat-burning genes, more fat was burned (shown by higher β-hydroxybutyrate), and key fat-burning switches (like PPARα and AMPK) stayed active.
Score breakdown, methodology, conflicts of interest, evidence analysis & raw study data
Publication
Journal
Endocrinology
Year
2011
Authors
Emma Barroso, R. Rodríguez-Calvo, Lucía Serrano-Marco, A. Astudillo, Jesús Balsinde, X. Palomer, M. Vázquez-Carrera
Related Content
Claims (5)
In mice eating a bad diet, a drug called GW501516 might help keep a key energy-sensing switch in the liver working properly, which could help their bodies handle the stress of unhealthy eating.
In mice on a high-fat diet, a drug called GW501516 might help liver cells better manage fat by turning up a key protein and activating a fat-burning switch.
In mice eating a fatty diet, a drug called GW501516 seems to turn on a chain reaction in the liver that helps burn fat more efficiently.
In mice eating a high-fat diet, taking a drug called GW501516 seems to boost a substance in their blood that shows their liver is burning more fat for energy.
In mice on a high-fat diet, a drug called GW501516 might boost a specific fat in the liver that could help turn on a fat-burning switch, making the body burn fat more efficiently.
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.